Marseille-Kliniken AG

EANS-Adhoc: - Marseille-Kliniken AG appoints new member to Management Board

-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 11.06.2010 Berlin, 11 June 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has appointed Dr. Thomas Klaue (52) to the Management Board effective 1 July 2010. He is undertaking the role of the Chief Financial Officer (CFO) and has also been appointed the Vice Chairman of the Management Board. This was resolved unanimously by the Supervisory Board in its meeting yesterday. The Management Board contract of Dr. Klaue has a term of three years. Until April 2010, Dr. Klaue served as the CFO of MediGene AG, one of the leading German biotech companies based in Martinsried. Prior to that position, he worked in a number of executive roles at Infineon AG and Dasa. Dr. Klaue is succeeding Claus Dobrowolski (53), who took over the role of interim CFO in April 2010. The Supervisory Board would like to thank Claus Dobrowolski for his valuable support. End of ad hoc release end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: Marseille-Kliniken AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Hillermann Consulting Christian Hillermann Investor Relations for Marseille-Kliniken AG Poststraße 14/16 20354 Hamburg Germany Tel.: +49-(0)40 / 320 279-10 Fax: +49-(0)40 / 320 279-114 www.hillermann-consulting.de Marseille-Kliniken AG Dr. Ute Buchheim Friedrich-Ebert-Str. 65 33330 Gütersloh Germany Tel.: +49-(0)5241 / 90 39-35 Fax: +49-(0)5241 / 90 39-39 www.marseille-kliniken.com Branche: Pharmaceuticals ISIN: DE0007783003 WKN: 778300 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Stuttgart / free trade Düsseldorf / free trade Hamburg / regulated dealing

Das könnte Sie auch interessieren: